Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131: 110708. https://doi.org/10.1016/j.biopha.2020.110708.

Article  PubMed  CAS  Google Scholar 

Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50:337–55. https://doi.org/10.1016/j.ecl.2021.05.013.

Article  PubMed  Google Scholar 

Tönnies T, Hoyer A, Brinks R, Kuss O, Hering R, Schulz M. Spatio-temporal trends in the incidence of type 2 diabetes in Germany-analysis of the claims data of 63 million persons with statutory health insurance from 2014 to 2019. Deutsches Arzteblatt Int. 2023. https://doi.org/10.3238/arztebl.m2022.0405.

Article  Google Scholar 

Tamayo T, Brinks R, Hoyer A, Kuß OS, Rathmann W. The prevalence and incidence of diabetes in Germany. Dtsch Arztebl Int. 2016;113:177–82. https://doi.org/10.3238/arztebl.2016.0177.

Article  PubMed  PubMed Central  Google Scholar 

Voeltz D, Tönnies T, Brinks R, Hoyer A. Future prevalence of type 2 diabetes-a comparative analysis of chronic disease projection methods. PLoS ONE. 2022;17: e0264739. https://doi.org/10.1371/journal.pone.0264739.

Article  PubMed  PubMed Central  CAS  Google Scholar 

International Diabetes Federation. IDF diabetes Atlas. 2021. https://www.diabetesatlas.org.

Ma C-X, Ma X-N, Guan C-H, Li Y-D, Mauricio D, Fu S-B. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21: 74. https://doi.org/10.1186/s12933-022-01516-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lehrke M, Marx N. Diabetes mellitus and heart failure. Am J Cardiol. 2017;120:S37–47. https://doi.org/10.1016/j.amjcard.2017.05.014.

Article  PubMed  CAS  Google Scholar 

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:83. https://doi.org/10.1186/s12933-018-0728-6.

Article  PubMed  PubMed Central  Google Scholar 

Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87. https://doi.org/10.1093/eurheartj/eht108.

Article  PubMed  Google Scholar 

Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, et al. Therapy of type 2 diabetes. Exp Clin Endocrinol Diabetes. 2019;127:S73–92. https://doi.org/10.1055/a-1018-9106.

Article  PubMed  Google Scholar 

Nauck MA, Wefers J, Meier JJ. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol. 2021;9:525–44. https://doi.org/10.1016/S2213-8587(21)00113-3.

Article  PubMed  CAS  Google Scholar 

Gabler M, Picker N, Geier S, Ley L, Aberle J, Lehrke M, et al. Guideline adherence and associated outcomes in the treatment of type 2 diabetes mellitus patients with an incident cardiovascular comorbidity: an analysis based on a large German claims dataset. Diabetes Ther. 2021;12:1209–26. https://doi.org/10.1007/s13300-021-01024-y.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Oude Wesselink SF, Lingsma HF, Robben PBM, Mackenbach JP. Guideline adherence and health outcomes in diabetes mellitus type 2 patients: a cross-sectional study. BMC Health Serv Res. 2015;15:22. https://doi.org/10.1186/s12913-014-0669-z.

Article  PubMed  PubMed Central  Google Scholar 

Papanas N, Elisaf M, Kotsa K, Melidonis A, Bousboulas S, Bargiota A, et al. Adherence to the national guidelines for follow-up protocol in subjects with type 2 diabetes mellitus in Greece: the GLANCE study. Diabetes Ther. 2020;11:2887–908. https://doi.org/10.1007/s13300-020-00935-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karlsson SA, Eliasson B, Franzén S, Miftaraj M, Svensson A-M, Andersson Sundell K. Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden. BMJ Open Diabetes Res Care. 2019;7: e000639. https://doi.org/10.1136/bmjdrc-2018-000639.

Article  PubMed  PubMed Central  Google Scholar 

Ständer S, Ketz M, Kossack N, Akumo D, Pignot M, Gabriel S, Chavda R. Epidemiology of prurigo nodularis compared with psoriasis in Germany: a claims database analysis. Acta Derm Venereol. 2020;100: adv00309. https://doi.org/10.2340/00015555-3655.

Article  PubMed  Google Scholar 

Wicke FS, Glushan A, Schubert I, Köster I, Lübeck R, Hammer M, et al. Performance of the adapted Diabetes Complications Severity Index translated to ICD-10. Am J Manag Care. 2019;25:e45–9.

PubMed  Google Scholar 

Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82. https://doi.org/10.1093/aje/kwq433.

Article  PubMed  Google Scholar 

AWMF-Register-Nr.: nvl-001, Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Typ-2Diabetes– Langfassung, 1. Auflage. Version 4. 2014. https://www.leitlinien.de/themen/diabetes/archiv/pdf/therapie-des-typ-2-diabetes/dm-therapie-1aufl-vers4-lang.pdf. Accessed 4 Apr 2023.

AWMF-Register Nr. 030–133: Hamann GF, Sander D, Röther J, Grau A et al. Deutsche Schlaganfall-Gesellschaft und Deutsche Gesellschaft für Neurologie. S3-Leitlinie– Teil 1 - Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke, Version 1. 2015. www.awmf.org. Accessed 4 Apr 2023.

ESC Pocket Guidelines. Therapie des akuten Herzinfarktes bei Patienten mit ST-Streckenhebung (STEMI), Version 2017: Kurzfassung der “ESC Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-segment Elevation“.

AWMF-Register-Nr.: nvl-006, Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz– Langfassung, 2. Auflage. Version 3. 2018. from: https://www.leitlinien.de/themen/herzinsuffizienz/archiv/pdf/herzinsuffizienz-2aufl-vers3-lang.pdf. Accessed 4 Apr 2023.

AWMF-Register-Nr.: nvl-004, Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische KHK– Langfassung, 4. Auflage. Version 1. 2016. https://www.leitlinien.de/themen/khk/archiv/pdf/khk-4aufl-vers1-lang-2.pdf.

ESC Pocket Guidelines. Akutes Koronarsyndrom ohne ST-Hebung (NSTE-ACS), Version 2015: Kurzfassung der "ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-segment Elevation“. https://leitlinien.dgk.org/files/18_2015_pocket_leitlinien_nste_acs.pdf. Accessed 4 Apr 2023.

Sattler ELP, Lee JS, Perri M. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging. 2013;30:383–99. https://doi.org/10.1007/s40266-013-0074-z.

Article  PubMed  Google Scholar 

Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of hyperglycaemia in type 2 diabetes, a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 2018;61:2461–98. https://doi.org/10.1007/s00125-018-4729-5.

Article  PubMed  Google Scholar 

Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–81. https://doi.org/10.1016/S0140-6736(10)61350-5.

Article  PubMed  CAS  Google Scholar 

Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart J-C, Haffner S, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the treating to new targets (TNT) study. Diabetes Care. 2006;29:1220–6. https://doi.org/10.2337/dc05-2465.

Article  PubMed  CAS  Google Scholar 

McAlister FA. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials. Eur Heart J. 2012;33:505–14. https://doi.org/10.1093/eurheartj/ehr400.

Article  PubMed  CAS  Google Scholar 

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–53. https://doi.org/10.1056/NEJM200001203420301.

Article  PubMed  CAS  Google Scholar 

Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393:31–9. https://doi.org/10.1016/S0140-6736(18)32590-X.

Article  PubMed  CAS  Google Scholar 

Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7:776–85.